Iron 

Preclinical Study

An in vivo study was performed to establish and validate the bioavailability of organic elemental iron (BioIron) in combination with or without BioPerine®.

The study involved a single oral dose of BioIron with BioPerine® (group I) or BioIron without BioPerine® (group II) administration to rabbits,  and blood samples  were collected at different time points.

Results showed that at 8 h time point, serum concentration of iron was significantly higher in group treated with BioIron containing BioPerine® (36.55±9.97 μg/ml) when compared to group treated with BioIron containing no BioPerine®.

Read More..

 

Clinical Study

In an open-label, non-randomized study, 30 subjects were provided with BioIron™ tablet (containing 8.5 mg of elemental iron and 2.5 mg of BioPerine® ) twice a day as a dietary supplement for a period of 56 days.

It was evident that treatment of iron deficiency anemia with BioIron™ for 56 days showed a statistically significant increase in hematologic values. Blood hemoglobin level was improved significantly. A significant improvement in serum iron (could be correlated to the immediate release of iron from BioIron™ into the systemic circulation); total iron binding capacity and serum ferritin level was also observed (Fig. 1 and 2).

 

Overall, BioIron™ was safe and effective in the management of iron deficiency anemia without any adverse events.

Read More..

About Sabinsa

Sabinsa Corporation is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.
Read More..

HeadQuarters

Sabinsa Corporation

20 Lake Drive 

East Windsor, NJ 08520, USA

Tel: +1.732.777.1111

Fax: +1.732.777.1443

info@sabinsa.com

Contact Presence

UA-10702234-1